Alvotech Petitions US FDA To Deny Interchangeability For Rival Stelara Biosimilars

 
• By Dave Wallace
  
Alvotech wants the FDA to deny interchangeability for certain ustekinumab biosimilars. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics